Cargando…

Role of circulating free DNA in colorectal cancer

The gradual elucidation of the underlying biology of colorectal cancer has provided new insights and therapeutic options for patients with metastatic disease which are selected according to predictive biomarkers. This precision medicine paradigm, however, is incomplete since not all eligible patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matikas, Alexios, Voutsina, Alexandra, Trypaki, Maria, Georgoulias, Vassilis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2016
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156847/ https://www.ncbi.nlm.nih.gov/pubmed/28035251 http://dx.doi.org/10.4251/wjgo.v8.i12.810

Ejemplares similares

Detection of KRAS Exon 2 Mutations in Circulating Tumor Cells Isolated by the ISET System from Patients with RAS Wild Type Metastatic Colorectal Cancer()
por: Matikas, Alexios, et al.
Publicado: (2017)

The Place of Targeted Agents in the Treatment of Elderly Patients with Metastatic Colorectal Cancer
por: Matikas, Alexios, et al.
Publicado: (2015)

Expression of truncated human epidermal growth factor receptor 2 on circulating tumor cells of breast cancer patients
por: Kallergi, Galatea, et al.
Publicado: (2015)

KRAS Genotypic Changes of Circulating Tumor Cells during Treatment of Patients with Metastatic Colorectal Cancer
por: Kalikaki, Aristea, et al.
Publicado: (2014)

Clinical challenges in the molecular characterization of circulating tumour cells in breast cancer
por: Lianidou, E S, et al.
Publicado: (2013)

Expression of insulin‐like growth factor‐1 receptor in circulating tumor cells of patients with breast cancer is associated with patient outcomes
por: Spiliotaki, Maria, et al.
Publicado: (2017)

Detection of circulating tumour cells before and following adjuvant chemotherapy and long-term prognosis of early breast cancer
por: Matikas, Alexios, et al.
Publicado: (2022)

Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancer
por: Polioudaki, Hara, et al.
Publicado: (2015)

Emerging role of cell-free DNA in kidney transplantation
por: Chopra, Bhavna, et al.
Publicado: (2021)

Detection of circulating tumour cells in colorectal cancer: Emerging techniques and clinical implications
por: Yadav, Alka, et al.
Publicado: (2021)

Toward the Development of a Circulating Free DNA-Based In Vitro Diagnostic Test for Infectious Diseases: a Review of Evidence for Tuberculosis
por: Fernández-Carballo, B. Leticia, et al.
Publicado: (2019)

Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC
por: Kalikaki, A, et al.
Publicado: (2008)

Role of surgery for colorectal cancer in the elderly
por: Biondi, Antonio, et al.
Publicado: (2016)

Circular RNAs in colorectal cancer: Possible roles in regulation of cancer cells
por: Taborda, María Isabel, et al.
Publicado: (2017)

Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer
por: Takai, Erina, et al.
Publicado: (2016)

Capecitabine in combination with oxaliplatin and bevacizumab (AXELOX) as 1st line treatment for fit and vulnerable elderly patients (aged >70 years) with metastatic colorectal cancer (mCRC): a multicenter phase II study of the Hellenic Oncology Research Group (HORG)
por: Vamvakas, Lambros, et al.
Publicado: (2014)

Circulating tumor DNA: Where are we now? A mini review of the literature
por: Galarza Fortuna, Gliceida Maria, et al.
Publicado: (2020)

Circulating tumor DNA for diagnosis, prognosis and treatment of gastrointestinal malignancies
por: Kirchweger, Patrick, et al.
Publicado: (2022)

Role of circulating microRNAs in liver diseases
por: Loosen, Sven H, et al.
Publicado: (2017)

Role of exosomal long non-coding RNAs in colorectal cancer
por: Sun, Ru, et al.
Publicado: (2021)

Role of netrin-1 and netrin-1 dependence receptors in colorectal cancers
por: Mehlen, P, et al.
Publicado: (2005)

Emerging role of autophagy in colorectal cancer: Progress and prospects for clinical intervention
por: Ma, Tian-Fei, et al.
Publicado: (2023)

BRAFV600E Mutation Analysis in Patients with Metastatic Colorectal Cancer (mCRC) in Daily Clinical Practice: Correlations with Clinical Characteristics, and Its Impact on Patients’ Outcome
por: Saridaki, Zacharenia, et al.
Publicado: (2013)

Role of surveillance imaging and endoscopy in colorectal cancer follow-up: Quality over quantity?
por: Liu, Shiru L, et al.
Publicado: (2019)

Role of near-infrared fluorescence in colorectal surgery
por: Zocola, Elodie, et al.
Publicado: (2021)

Emerging role of colorectal mucus in gastroenterology diagnostics
por: Nooredinvand, Hesam Ahmadi, et al.
Publicado: (2022)

Direct comparison study of DNA methylation markers in EpCAM-positive circulating tumour cells, corresponding circulating tumour DNA, and paired primary tumours in breast cancer
por: Chimonidou, Maria, et al.
Publicado: (2017)

Evaluation of PD-L1/PD-1 on circulating tumor cells in patients with advanced non-small cell lung cancer
por: Kallergi, Galatea, et al.
Publicado: (2018)

Role of gut microbiome in regulating the effectiveness of metformin in reducing colorectal cancer in type 2 diabetes
por: Huang, Qi-You, et al.
Publicado: (2020)

Prognostic Value of KRAS Mutations in Colorectal Cancer Patients
por: Koulouridi, Asimina, et al.
Publicado: (2022)

Current noninvasive tests for colorectal cancer screening: An overview of colorectal cancer screening tests
por: Song, Le-Le, et al.
Publicado: (2016)

PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer
por: Papadaki, C, et al.
Publicado: (2014)

The role of DNA sequence in centromere formation
por: Lamb, Jonathan C, et al.
Publicado: (2003)

The measurement and therapeutic implications of circulating tumour cells in breast cancer
por: Smerage, J B, et al.
Publicado: (2006)

Nanotechnology for colorectal cancer detection and treatment
por: Gogoi, Purnima, et al.
Publicado: (2022)

Genetic heterogeneity of colorectal cancer and the microbiome
por: Senchukova, Marina A
Publicado: (2023)

Systemic treatment for metastatic colorectal cancer
por: Leowattana, Wattana, et al.
Publicado: (2023)

Microbiota regulation in constipation and colorectal cancer
por: Wang, Li-Wei, et al.
Publicado: (2023)

Role of endoscopy in the surveillance and management of colorectal neoplasia in inflammatory bowel disease
por: Manchanda, Shaad, et al.
Publicado: (2019)

Role of liver transplantation in the management of colorectal liver metastases: Challenges and opportunities
por: Tasoudis, Panagiotis T, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t4soec9tkj5en3l609umbqbscc